Results 181 to 190 of about 2,906,691 (234)
Some of the next articles are maybe not open access.
CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER
Surgical Clinics of North America, 2001Cytoreductive surgery is a crucial component of the management of cancer of the ovary. Surgical cytoreduction of ovarian cancer volume has been associated with an increase in survival in all settings in which it has been studied. This association seems strongest, and the benefits of aggressive surgery are generally greatest, in patients with ...
T C, Randall, S C, Rubin
openaire +2 more sources
Technical aspects of cytoreductive surgery
Journal of Surgical Oncology, 2008AbstractAt the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Five conflicting points were discussed: radicality of the peritonectomy procedure, cytoreduction of neoplastic nodules <2 ...
Shigeki, Kusamura +4 more
openaire +2 more sources
Patient Selection for Cytoreductive Surgery
Surgical Oncology Clinics of North America, 2018The peritoneal malignancies span the biologic spectrum of aggressiveness from the indolent growth pattern and superficial nature of well-differentiated mucinous appendiceal adenocarcinoma to the rapidly growing and invasive nature of poorly differentiated signet ring cell adenocarcinomas of the appendix, colon, and stomach.
Travis E, Grotz +2 more
openaire +2 more sources
Cytoreductive surgery for ovarian cancer
European Journal of Surgical Oncology (EJSO), 2003The aim of this study is to describe the technique of managing peritoneal dissemination in patients with ovarian cancer, based on radical surgical excision and, later, perioperative chemotherapy.Treatments included complete surgical resection of the peritoneal disease, and intraperitoneal intraoperative and postoperative chemotherapy, using Adriamycin ...
D M, Kecmanovic +4 more
openaire +2 more sources
Surgery, gynecology & obstetrics, 1990
The results of experimental studies suggest that cytoreduction has important potential benefits. In the laboratory setting, reduction of tumor burden increases the sensitivity of remaining tumor to chemotherapy and radiation therapy by increasing the proportion of proliferating tumor cells, by decreasing the number of necessary chemotherapeutic cycles ...
R J, Wong, J J, DeCosse
openaire +1 more source
The results of experimental studies suggest that cytoreduction has important potential benefits. In the laboratory setting, reduction of tumor burden increases the sensitivity of remaining tumor to chemotherapy and radiation therapy by increasing the proportion of proliferating tumor cells, by decreasing the number of necessary chemotherapeutic cycles ...
R J, Wong, J J, DeCosse
openaire +1 more source
Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei.
Surgical oncology, 2019INTRODUCTION The optimal treatment for pseudomyxoma peritonei (PMP) combines complete cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC).
L. Benhaim +7 more
semanticscholar +1 more source
Surgery, 2019
Background: The purpose of this study was to investigate the safety of laparoscopic cytoreductive surgery versus open surgery for patients with limited peritoneal metastases from colorectal cancer.
S. Ha +10 more
semanticscholar +1 more source
Background: The purpose of this study was to investigate the safety of laparoscopic cytoreductive surgery versus open surgery for patients with limited peritoneal metastases from colorectal cancer.
S. Ha +10 more
semanticscholar +1 more source
SECONDARY CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER
Obstetrics and Gynecology Clinics of North America, 1994Secondary cytoreduction to optimal levels can be successfully accomplished in a substantial number of ovarian cancer patients and in a variety of clinical settings. Although frequently complex, secondary operations can be performed with acceptable morbidity. All operations should be undertaken by experienced oncologic surgeons.
T W, Burke, M, Morris
openaire +2 more sources
Annals of Surgical Oncology, 2021
Cascales Campos Pedro Antonio +10 more
semanticscholar +1 more source
Cascales Campos Pedro Antonio +10 more
semanticscholar +1 more source
European Journal of Surgical Oncology, 2019
BACKGROUND The effects of Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) and CytoReductive Surgery (CRS) for ovarian cancer patients remain controversial.
Yizi Wang +5 more
semanticscholar +1 more source
BACKGROUND The effects of Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) and CytoReductive Surgery (CRS) for ovarian cancer patients remain controversial.
Yizi Wang +5 more
semanticscholar +1 more source